SPOTLIGHT -
Selecting the Right Patients for Anti-VEGF Biosimilar Therapy
Read More
Impact of Biosimilars on the Healthcare System
Key Clinical Findings on the Efficacy, Safety Profile and Immunogenicity of Biosimilar SB11
Review of the Phase III Clinical Trial for Biosimilar SB11
Biosimilar Approval Process by Regulatory Bodies
Overview of Biosimilars
Need for Awareness About Biosimilars